EP1841406A4 - Methods and formulations - Google Patents

Methods and formulations

Info

Publication number
EP1841406A4
EP1841406A4 EP05854851A EP05854851A EP1841406A4 EP 1841406 A4 EP1841406 A4 EP 1841406A4 EP 05854851 A EP05854851 A EP 05854851A EP 05854851 A EP05854851 A EP 05854851A EP 1841406 A4 EP1841406 A4 EP 1841406A4
Authority
EP
European Patent Office
Prior art keywords
formulations
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05854851A
Other languages
German (de)
French (fr)
Other versions
EP1841406A2 (en
Inventor
Simon M Blake
William Henry Miller
Amyn Sayani
H Jeffrey Wilkens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of EP1841406A2 publication Critical patent/EP1841406A2/en
Publication of EP1841406A4 publication Critical patent/EP1841406A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
EP05854851A 2004-12-21 2005-12-20 Methods and formulations Withdrawn EP1841406A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63782404P 2004-12-21 2004-12-21
PCT/US2005/046204 WO2006069079A2 (en) 2004-12-21 2005-12-20 Methods and formulations

Publications (2)

Publication Number Publication Date
EP1841406A2 EP1841406A2 (en) 2007-10-10
EP1841406A4 true EP1841406A4 (en) 2008-06-25

Family

ID=36602271

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05854851A Withdrawn EP1841406A4 (en) 2004-12-21 2005-12-20 Methods and formulations

Country Status (6)

Country Link
EP (1) EP1841406A4 (en)
JP (1) JP2008524334A (en)
AR (1) AR052823A1 (en)
PE (1) PE20060870A1 (en)
TW (1) TW200635902A (en)
WO (1) WO2006069079A2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998014192A1 (en) * 1996-10-02 1998-04-09 Smithkline Beecham Corporation Vitronectin receptor antagonists
WO2000033838A1 (en) * 1998-12-04 2000-06-15 Smithkline Beecham Corporation Vitronectin receptor antagonist
WO2002083125A1 (en) * 2001-04-10 2002-10-24 Smithkline Beecham Corporation Method of inhibiting adhesion formation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000046215A1 (en) * 1999-02-03 2000-08-10 Merck & Co., Inc. Benzazepine derivatives as alpha-v integrin receptor antagonists

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998014192A1 (en) * 1996-10-02 1998-04-09 Smithkline Beecham Corporation Vitronectin receptor antagonists
WO2000033838A1 (en) * 1998-12-04 2000-06-15 Smithkline Beecham Corporation Vitronectin receptor antagonist
WO2002083125A1 (en) * 2001-04-10 2002-10-24 Smithkline Beecham Corporation Method of inhibiting adhesion formation

Also Published As

Publication number Publication date
WO2006069079A3 (en) 2007-04-19
WO2006069079A2 (en) 2006-06-29
JP2008524334A (en) 2008-07-10
AR052823A1 (en) 2007-04-04
PE20060870A1 (en) 2006-08-16
TW200635902A (en) 2006-10-16
EP1841406A2 (en) 2007-10-10

Similar Documents

Publication Publication Date Title
GB0422525D0 (en) Dermatological compositions and methods
EP1804831A4 (en) Listeria-based and llo-based vaccines
IL209494A (en) Insulin-oligomer monoconjugates, formulations and uses thereof
EP1802588A4 (en) Substituted amino-pyrimidones and uses thereof
EP1841397A4 (en) Formulations and treatments for trichology
ZA200701820B (en) Substituted phenylaminothiazoles and use thereof
HK1101911A1 (en) Tetrahydrocarbozoles and derivatives
GB0411940D0 (en) Methods and compositions
EP1701725A4 (en) Methods and compositions
IL191072A0 (en) Therapeutic compositions and methods
ZA200706128B (en) Pesticide compositions and methods
GB0414825D0 (en) Gel formulations and uses thereof
IL179497A0 (en) Carboranylporphyrins and uses thereof
EP1763358A4 (en) Appetite-suppressing compositions and methods
EP1773386A4 (en) Vaccine compositions and methods
EP1807071A4 (en) Antipyretic compositions and methods
IL178888A0 (en) Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives
PL2215908T3 (en) 2-Alkyl-cycloalk(en)yl-carboxamides and their use as fungizides
EP1737565A4 (en) Cos-claus configurations and methods
IL184062A0 (en) Visco-supplement composition and methods
IL180365A0 (en) Carboranylporphyrins and uses thereof
IL181300A0 (en) Photosensitizer formulations and uses thereof
EP1810976A4 (en) Benzonaphthaceneglycoside derivative and use thereof
GB0424552D0 (en) Methods and means
GB0403847D0 (en) Methods and means

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070718

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK YU

RIC1 Information provided on ipc code assigned before grant

Ipc: A01N 25/00 20060101ALI20071108BHEP

Ipc: A01N 65/00 20060101AFI20071108BHEP

RAX Requested extension states of the european patent have changed

Extension state: HR

Payment date: 20070718

A4 Supplementary search report drawn up and despatched

Effective date: 20080526

17Q First examination report despatched

Effective date: 20080721

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20081202